|
RNL Bio Company Limited - Company Profile Snapshot
| Company Profile: |
RNL Bio Company Limited |
| Ticker: |
003190 |
| Exchanges: |
SEO |
| 2008 Sales: |
26,370,000,000 |
| Major Industry: |
Paper |
| Sub Industry: |
Printing & Writing Paper |
| Country: |
KOREA (SOUTH) |
| Employees: |
128 |
Business Description
RNL Bio Company Limited. The Group's principal activity is manufacturing cell therapy products. Its products include stem cells, lipostem-DM remedy for diabetes mellitus, astrostem remedy for spinal cord injury, vascostem remedy for ischemic cardiac and cerebral infarction and cancerstem remedy for cancers, endocrine remedy for anti-diabetes mellitus and bio safety products.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
